Wolfgang Mück - Wissenschaftliche Veröffentlichungen

(1 - 3 von 5

)

Holographic Renormalization of Two-Point Functions in Non-AdS/Non-CFT

epub.ub.uni-muenchen.de

Haack, Michael und Mueck, Wolfgang (2010): Holographic Renormalization of Two-Point Functions in Non-AdS/Non-CFT. In: Advances in High Energy Physics, Vol , …

BAY 58–2667, a soluble guanylate cyclase activator, has a ...

bmcpharma.biomedcentral.com

von R Frey · — Reiner Frey, Wolfgang Mück, Ulrike Artmeier-Brandt, Gerrit Weimann & Georg Wensing. Global Biostatistics, Bayer HealthCare AG, ... › ...

Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in...

thrombosisjournal.biomedcentral.com

Unlike traditional anticoagulants, the more recently developed agents rivaroxaban, dabigatran and apixaban target specific factors in the coagulation cascade...

Verwandte Suchanfragen zu Wolfgang Mück

Christian Peter Schmidt
Jürgen Büdel
Norbert Bodewig

Peter Spiegel
Stefan Mück
Frank Ter Duis

Person "Mück" (3)
Vorname "Wolfgang" (62599)
Name "Mück" (520)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Wissenschaftliche Veröffentlichungen Wolfgang Mück

Holographic Renormalization of Two-Point Functions in Non-AdS/Non-CFT

BAY 58–2667, a soluble guanylate cyclase activator, has a ...

Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in...